US2013276153A1PendingUtilityA1
Production of Transgenic Avians Using Improved Retroviral Vectors
Est. expiryDec 29, 2024(expired)· nominal 20-yr term from priority
C12N 2740/11043C07K 14/70521A01K 67/0275C12N 15/8509A01K 2227/30C12N 2830/15C12N 2830/008C12N 15/09C07K 14/56A01K 2267/01C12N 7/00C12N 2830/90A01K 67/0278C07K 2319/30A01K 2207/15A01K 2217/052C12N 2800/24C12N 15/86C12N 2015/8518C12N 15/02
63
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A transgenic avian containing in its genome an exogenous nucleotide sequence which includes a promoter component and a vector with reduced promoter interference wherein the exogenous nucleotide sequence is integrated into the genome and the avian.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of producing an exogenous protein comprising producing a transgenic avian having a nucleotide sequence comprising a self-inactivation (SIN) vector having no selectable marker and a promoter component operably linked to an exogenous coding sequence, wherein the exogenous coding sequence is expressed in oviduct cells of the avian; and obtaining the exogenous protein from egg white of the avian.
2 . The method of claim 1 , wherein the exogenous coding sequence encodes a human protein.
3 . The method of claim 1 , wherein the exogenous coding sequence encodes a therapeutic protein.
4 . The method of claim 1 , wherein the promoter component comprises a functional promoter sequence of a promoter selected from the group consisting of avian ovalbumin promoter component, avian ovomucoid promoter component, avian lysozyme promoter component and avian conalbumin promoter component.
5 . The method of claim 1 , wherein the avian is selected from the group consisting of a chicken, a turkey and a quail.
6 . The method of claim 1 , wherein the self-inactivation vector comprises nucleotide sequences set forth in SEQ ID NOs: 25, 26 and 29 or nucleotide sequences having at least 90% identity thereto.
7 . The method of claim 1 , wherein the promoter component comprises a nucleotide sequence having at least 90% identity to the sequence set forth in 5209 through 8311 of SEQ ID NO:22.
8 . A transgenic avian containing in its genome an exogenous nucleotide sequence comprising a promoter component and a self-inactivation (SIN) vector having no selectable marker, wherein the avian produces an exogenous protein.
9 . The transgenic avian of claim 8 , wherein the promoter component comprises a functional promoter sequence of a promoter selected from the group consisting of avian ovalbumin promoter component, avian ovomucoid promoter component and avian lysozyme promoter component.
10 . The transgenic avian of claim 8 , wherein the avian is selected from the group consisting of a chicken, a turkey and a quail.
11 . The transgenic avian of claim 8 , wherein the exogenous nucleotide sequence comprises nucleotide sequences set forth in SEQ ID NOs: 25, 26 and 29 or nucleotide sequences having at least 90% identity thereto.
12 . The transgenic avian of claim 8 , wherein the exogenous nucleotide sequence comprises a nucleotide sequence having at least 90% identity to the sequence set forth in 5209 through 8311 of SEQ ID NO:22.Join the waitlist — get patent alerts
Track US2013276153A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.